Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Protagonist Therapeutics is a US-based biotech company specializing in the development of innovative peptide-based therapeutics. Through cutting-edge platforms, the company addresses complex diseases in hematology and gastroenterology, aiming to sustainably improve patient care and treatment outcomes.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Protagonist Therapeutics is scheduled to report its next quarterly earnings on 11/05/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Protagonist Therapeutics last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 2.29 USD.
Across its last 3 earnings reports, Protagonist Therapeutics stock moved by ±4.2% on average the following day. The largest reaction was +6.5% on 08/05/2026; 3 of 3 reactions were positive.
Protagonist Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.